Drug Shortage Report for APTIOM
Report ID | 224106 |
Drug Identification Number | 02426870 |
Brand name | APTIOM |
Common or Proper name | eslicarbazepine acetate tablets |
Company Name | SUMITOMO PHARMA CANADA, INC. |
Market Status | MARKETED |
Active Ingredient(s) | ESLICARBAZEPINE ACETATE |
Strength(s) | 400MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 30 tablets |
ATC code | N03AF |
ATC description | ANTIEPILEPTICS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2024-04-15 |
Actual start date | |
Estimated end date | 2024-04-30 |
Actual end date | 2024-04-15 |
Shortage status | Resolved |
Updated date | 2024-04-16 |
Company comments | Company anticipates the shortage will be limited from a few days to a few weeks. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 7025 LANGER DRIVE MISSISSAUGA, ONTARIO CANADA L5N 0E8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2024-04-16 | English | Compare |
v6 | 2024-04-15 | French | Compare |
v5 | 2024-04-15 | English | Compare |
v4 | 2024-04-02 | French | Compare |
v3 | 2024-04-02 | English | Compare |
v2 | 2024-04-02 | English | Compare |
v1 | 2024-04-02 | English | Compare |
Showing 1 to 7 of 7